Stockscreener 앱 받기
68.81
0.22%
-0.15
시간 외 거래:
68.81
전일 마감가:
$68.96
열려 있는:
$68.72
하루 거래량:
524.00K
Relative Volume:
0.79
시가총액:
$2.90B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-14.83
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+4.16%
1개월 성능:
+15.78%
6개월 성능:
+32.56%
1년 성능:
+54.66%
1일 변동 폭
$68.69
$70.84
1주일 범위
$65.99
$70.84
52주 변동 폭
$38.51
$76.81
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
68.81 | 2.91B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Forecasting Tarsus Pharmaceuticals Inc. price range with options dataEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
What’s the recovery path for long term holders of Tarsus Pharmaceuticals Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Is Tarsus Pharmaceuticals Inc. stock cheap at current valuationTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Is Tarsus Pharmaceuticals Inc. showing signs of accumulation2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Is Tarsus Pharmaceuticals Inc. stock a safe investment in uncertain marketsLong Setup & Real-Time Stock Entry Alerts - newser.com
How analysts rate Tarsus Pharmaceuticals Inc. stock todayWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Tarsus Pharmaceuticals Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Tarsus Pharmaceuticals (TARS) to Release Earnings on Tuesday - MarketBeat
What to expect from Tarsus Pharmaceuticals Inc. in the next 30 days2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Can Tarsus Pharmaceuticals Inc. recover in the next quarterPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Jennison Associates LLC Trims Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Applying sector rotation models to Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Will Tarsus Pharmaceuticals Inc. stock deliver shareholder value2025 Market Overview & Weekly High Return Opportunities - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
Tarsus Pharmaceuticals Inc. stock trend outlook and recovery pathGold Moves & Risk Controlled Stock Alerts - newser.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockWeekly Investment Report & Verified Momentum Watchlists - newser.com
Allianz Asset Management GmbH Purchases New Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewswire
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Is Tarsus Pharmaceuticals Inc. stock attractive for long term wealth building2025 Dividend Review & Technical Entry and Exit Tips - Fundação Cultural do Pará
How Tarsus Pharmaceuticals Inc. stock performs in weak economy2025 Performance Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Does Tarsus Pharmaceuticals Inc. qualify in momentum factor screening2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):